The murine autoimmune diabetes model: NOD and related strains.
Kikutani
H
H
Institute for Molecular and Cellular Biology, Osaka University, Japan.
Makino
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D016207:Cytokines / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D004198:Disease Susceptibility / Q000276:immunology; D005260:Female; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006183:H-2 Antigens / Q000235:genetics / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD / Q000235:genetics / Q000378:metabolism; D008822:Mice, Transgenic / Q000276:immunology; D051381:Rats; D011913:Rats, Inbred BB / Q000235:genetics / Q000276:immunology; D013311:Streptozocin; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D001324:Autoantigens; D016207:Cytokines; D005819:Genetic Markers; D006183:H-2 Antigens; D000949:Histocompatibility Antigens Class II; C024138:I-E-antigen; D007166:Immunosuppressive Agents; D013311:Streptozocin